As of 2026-09-23, the Relative Valuation of Britannia Life Sciences Inc (BLAB.CN) is 0.07 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.07 CAD, the upside of Britannia Life Sciences Inc based on Relative Valuation is -1.2%.
The range of the Relative Valuation is 0.07 - 0.07 CAD.
| Range | Selected | |
| Trailing P/E multiples | 1.1x - 1.1x | 1.1x |
| Forward P/E multiples | 1.1x - 1.1x | 1.1x |
| Fair Price | 0.07 - 0.07 | 0.07 |
| Upside | -1.2% - -1.2% | -1.2% |
| Date | P/E |
| 2026-09-14 | 1.11 |
| 2026-09-11 | 1.11 |
| 2026-09-08 | 1.11 |
| 2026-09-04 | 1.11 |
| 2026-09-03 | 1.11 |
| 2026-09-02 | 1.11 |
| 2026-09-01 | 1.11 |
| 2026-08-31 | 1.11 |
| 2026-08-27 | 1.11 |
| 2026-08-25 | 1.11 |
| 2026-08-24 | 1.03 |
| 2026-08-21 | 1.03 |
| 2026-08-19 | 1.11 |
| 2026-08-13 | 1.03 |
| 2026-08-12 | 1.03 |
| 2026-08-11 | 1.03 |
| 2026-08-07 | 1.03 |
| 2026-08-06 | 1.03 |
| 2026-08-05 | 1.11 |
| 2026-07-31 | 1.11 |
| 2026-07-29 | 1.03 |
| 2026-07-28 | 1.03 |
| 2026-07-27 | 1.03 |
| 2026-07-24 | 1.03 |
| 2026-07-22 | 1.11 |
| 2026-07-21 | 1.03 |
| 2026-07-20 | 1.11 |
| 2026-07-17 | 1.11 |
| 2026-07-16 | 1.03 |
| 2026-07-14 | 1.11 |
| 2026-07-08 | 1.11 |
| 2026-07-07 | 1.11 |
| 2026-07-06 | 1.19 |
| 2026-07-02 | 1.19 |
| 2026-06-29 | 1.19 |
| 2026-06-23 | 1.19 |
| 2026-06-22 | 1.19 |